NVAX

Novavax, Inc.

Halal Rating :
Comfortable
Last Price $8.72 Last updated:
Market Cap $1.98b
7D Change -4.28%
1 Year Change 76.52%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange NASDAQ
Next Earnings Date Nov. 7, 2024

Novavax, Inc. is a biotechnology company focused on the development and commercialization of vaccines to prevent serious infectious diseases. The company's main product is NVX-CoV2373, a protein-based vaccine for COVID-19. They also have vaccines in development for seasonal influenza and other infectious diseases.

The company uses its proprietary recombinant nanoparticle vaccine technology and Matrix-M™ adjuvant in its development programs. This technology allows for the creation of vaccine particles that mimic the molecular structure of the target virus.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $84.51m $222.77m - $4.24m 0.00% 1.90%
June 30, 2024 $415.48m $258.63m - $4.14m 0.00% 1.60%
March 31, 2024 $93.86m $242.8m - $4.11m 0.00% 1.69%

Company Impact

Help us evaluate Novavax, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates